Physician profile
Virginia Wright
NPI 1841602778
$2,334.36
in general payments reported to CMS, 2019-2025
24 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $55.92 · 2021: $465 · 2022: $696 · 2023: $115 · 2024: $328 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $387.66 | 2021-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $291.86 | 2019-2025 | Rybelsus, Ozempic, Sogroya |
| Dexcom, INC. | $270.84 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $192.20 | 2020-2024 | Mounjaro, Humulin, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.32 | 2019-2022 | |
| Amgen INC. | $164.30 | 2019-2025 | Evenity, Prolia, Repatha |
| Sanofi-Aventis U.S. LLC | $97.95 | 2019-2024 | |
| Abbvie INC. | $87.81 | 2019-2022 | |
| Corcept Therapeutics | $81.69 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $78.05 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $76.56 | 2019 | |
| Shire North American Group INC | $65.45 | 2019 | |
| Grt US Holding, INC. | $48.06 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $47.05 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $44.96 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $35.46 | 2019 | |
| Medtronic, INC. | $28.30 | 2024 | Intellis Adaptivestim, Minimed 780g |
| Radius Health, INC. | $27.89 | 2019 | |
| Beta Bionics, INC. | $26.18 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Neurocrine Biosciences, INC. | $25.71 | 2025 | |
| Kyowa Kirin, INC. | $23.21 | 2024 | Crysvita |
| Xeris Pharmaceuticals, INC. | $20.22 | 2025 | Recorlev |
| Insulet Corporation | $13.89 | 2022 | |
| Becton, Dickinson and Company | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.